# EDGAR Filing Document

**Accession Number:** 0001877184
**File Stem:** 0000950170-25-113058
**Filing Date:** 2025-9
**Character Count:** 6253
**Document Hash:** 999a5b0a199ee9ab76c13503103d9eed
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-113058.hdr.sgml**: 20250904

**ACCESSION NUMBER**: 0000950170-25-113058

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 10

**CONFORMED PERIOD OF REPORT**: 20250903

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250904

**DATE AS OF CHANGE**: 20250904

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KESTRA MEDICAL TECHNOLOGIES, LTD.
- **CENTRAL INDEX KEY:** 0001877184
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42549
- **FILM NUMBER:** 251294031

**BUSINESS ADDRESS:**
- **STREET 1:** 3933 LAKE WASHINGTON BLVD NE
- **STREET 2:** SUITE 200
- **CITY:** KIRKLAND
- **STATE:** WA
- **ZIP:** 98033
- **BUSINESS PHONE:** (425) 279-8002

**MAIL ADDRESS:**
- **STREET 1:** 3933 LAKE WASHINGTON BLVD NE
- **STREET 2:** SUITE 200
- **CITY:** KIRKLAND
- **STATE:** WA
- **ZIP:** 98033

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** September 3, 2025<br>

------

KESTRA MEDICAL TECHNOLOGIES, LTD.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Bermuda | 001-42549 | Not Applicable |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 3933 Lake Washington Blvd NE <br>Suite 200 |  |  |
| Kirkland**,** Washington |  | 98033 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: (**425**)** 279-8002<br>

**Not applicable**<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Shares, par value $1.00 per share | KMTS | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 5.07. Submission of Matters to a Vote of Security Holders.
The Kestra Medical Technologies, Ltd. (the "Company") 2025 annual general meeting of shareholders (the "2025 Annual Meeting") was held on September 3, 2025. The total number of the Company's common shares voted in person or by proxy at the 2025 Annual Meeting was 48,835,102, representing approximately 95% of the 51,348,656 shares that were outstanding and entitled to vote as of July 7, 2025, the record date of the 2025 Annual Meeting. Voting results for each matter submitted to a vote at the 2025 Annual Meeting are provided below.

**Proposal 1 – Election of Directors**

The shareholders elected each of the two persons named below to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified, with the vote totals as set forth in the table below:

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**<u>Nominee</u>** | &nbsp;&nbsp;**<u>For</u>** | &nbsp;&nbsp;**<u>Against</u>** | &nbsp;&nbsp;**<u>Abstain</u>** |
| &nbsp;&nbsp;Conor Hanley | &nbsp;&nbsp;43,121,331 | &nbsp;&nbsp;3,640,519 | &nbsp;&nbsp;14,870 |
| &nbsp;&nbsp;Elizabeth Kwo | &nbsp;&nbsp;43,118,417 | &nbsp;&nbsp;3,643,439 | &nbsp;&nbsp;14,864 |

---

**Proposal 2 – Ratification of Independent Registered Public Accounting Firm** 

The shareholders ratified the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2026, with the vote totals set forth in the table below:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**<u>For</u>** | &nbsp;&nbsp;**<u>Against</u>** | &nbsp;&nbsp;**<u>Abstain</u>** |
| &nbsp;&nbsp;48,814,793 | &nbsp;&nbsp;5,444 | &nbsp;&nbsp;14,865 |

---

**Proposal 3 – Approval of 2025 Employee Stock Purchase Plan**

The shareholders approved the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan, with the vote totals set forth in the table below:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**<u>For</u>** | &nbsp;&nbsp;**<u>Against</u>** | &nbsp;&nbsp;**<u>Abstain</u>** |
| &nbsp;&nbsp;45,801,106 | &nbsp;&nbsp;975,504 | &nbsp;&nbsp;110 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Kestra Medical Technologies, Ltd.** | **Kestra Medical Technologies, Ltd.** |
| Date: September 4, 2025 | By: | /s/ Brian Webster |
|  | Name: | Brian Webster |
|  | Title: | President and Chief Executive Officer |

---

------